Article
The changes of leukocyte telomere length and telomerase activity after sitagliptin intervention in newly diagnosed type 2 diabetes
5 Jul 2014
Abstract excerpt
BACKGROUND: In recent years, increasing evidence suggests a potential importance of telomere biology in type 2 diabetes. The aim of this study was to determine whether sitagliptin, a medicine generally used in diabetes, can influence the telomere and telomerase in newly diagnosed type 2 diabetic patients. METHODS: Type 2 diabetic patients (T2D, n = 38) and non-diabetic subjects (control, n = 31) were randomly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
